Aurone derivatives as Vps34 inhibitors that modulate autophagy

被引:23
作者
Li, Guodong [1 ]
Boyle, Joshua William [2 ]
Ko, Chung-Nga [3 ]
Zeng, Wu [4 ]
Wong, Vincent Kam Wai [4 ]
Wan, Jian-Bo [1 ]
Chan, Philip Wai Hong [2 ,5 ]
Ma, Dik-Lung [3 ]
Leung, Chung-Hang [1 ]
机构
[1] Univ Macau, State Key Lab Qual Res Chinese Med, Inst Chinese Med Sci, Macau 999078, Peoples R China
[2] Monash Univ, Sch Chem, Clayton, Vic 3800, Australia
[3] Hong Kong Baptist Univ, Dept Chem, Hong Kong 999077, Peoples R China
[4] Macau Univ Sci & Technol, State Key Lab Qual Res Chinese Med, Macau 999078, Peoples R China
[5] Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England
基金
澳大利亚研究理事会; 中国国家自然科学基金;
关键词
Autophagy; Natural products; Vps34; Inhibitor; Structure-based virtual screening; Vesicle trafficking; Heart or liver damage; Aurgone derivative; DISCOVERY; PIK3C3/VPS34; CANCER; LIVER; ENDOCYTOSIS; HEART; P62; KEY;
D O I
10.1016/j.apsb.2019.01.016
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We report in this study the identification of a natural product-like antagonist (la) of Vps34 as a potent autophagy modulator via structure-based virtual screening. Aurone derivative la strongly inhibited Vps34 activity in cell-free and cell-based assays. Significantly, la prevents autophagy in human cells induced either by starvation or by an mTOR inhibitor. In silico modeling and kinetic data revealed that la could function as an ATP-competitive inhibitor of Vps34. Moreover, it suppressed autophagy in vivo and without inducing heart or liver damage in mice. la could be utilized as a new motif for more selective and efficacious antagonists of Vps34 for the potential treatment of autophagy-related human diseases. (C) 2019 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.
引用
收藏
页码:537 / 544
页数:8
相关论文
共 38 条
  • [1] An in-silico approach to predict and exploit synthetic lethality in cancer metabolism
    Apaolaza, Inigo
    San Jose-Eneriz, Edurne
    Tobalina, Luis
    Miranda, Estibaliz
    Garate, Leire
    Agirre, Xabier
    Prosper, Felipe
    Planes, Francisco J.
    [J]. NATURE COMMUNICATIONS, 2017, 8
  • [2] The class III phosphatidylinositol 3-kinase PIK3C3/VPS34 regulates endocytosis and autophagosome-autolysosome formation in podocytes
    Bechtel, Wibke
    Helmstaedter, Martin
    Balica, Jan
    Hartleben, Bjoern
    Schell, Christoph
    Huber, Tobias B.
    [J]. AUTOPHAGY, 2013, 9 (07) : 1097 - 1099
  • [3] Bilanges Benoit, 2014, Biochem J, V464, pe7, DOI 10.1042/BJ20141218
  • [4] Novel fluorescent probes of 10-hydroxyevodiamine: autophagy and apoptosis-inducing anticancer mechanisms
    Chen, Shuqiang
    Dong, Guoqiang
    Wu, Shanchao
    Liu, Na
    Zhang, Wannian
    Sheng, Chunquan
    [J]. ACTA PHARMACEUTICA SINICA B, 2019, 9 (01) : 144 - 156
  • [5] Choi AMK, 2013, NEW ENGL J MED, V368, P1845, DOI [10.1056/NEJMra1205406, 10.1056/NEJMc1303158]
  • [6] p62 Is a Key Regulator of Nutrient Sensing in the mTORC1 Pathway
    Duran, Angeles
    Amanchy, Ramars
    Linares, Juan F.
    Joshi, Jayashree
    Abu-Baker, Shadi
    Porollo, Aleksey
    Hansen, Malene
    Moscat, Jorge
    Diaz-Meco, Maria T.
    [J]. MOLECULAR CELL, 2011, 44 (01) : 134 - 146
  • [7] Chemical modulators of autophagy as biological probes and potential therapeutics
    Fleming, Angeleen
    Noda, Takeshi
    Yoshimori, Tamotsu
    Rubinsztein, David C.
    [J]. NATURE CHEMICAL BIOLOGY, 2011, 7 (01) : 9 - 17
  • [8] Human VPS34 is required for internal vesicle formation within multivesicular endosomes
    Futter, CE
    Collinson, LM
    Backer, JM
    Hopkins, CR
    [J]. JOURNAL OF CELL BIOLOGY, 2001, 155 (07) : 1251 - 1263
  • [9] Drug discovery approaches targeting the PI3K/Akt pathway in cancer
    Garcia-Echeverria, C.
    Sellers, W. R.
    [J]. ONCOGENE, 2008, 27 (41) : 5511 - 5526
  • [10] Class III PI3K Vps34: essential roles in autophagy, endocytosis, and heart and liver function
    Jaber, Nadia
    Zong, Wei-Xing
    [J]. INOSITOL PHOSPHOLIPID SIGNALING IN PHYSIOLOGY AND DISEASE, 2013, 1280 : 48 - 51